Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 37, 2020 - Issue 6
Submit an article Journal homepage
224
Views
6
CrossRef citations to date
0
Altmetric
Report

Imatinib-Induced Hypogammaglobulinemia in Children and Adolescents with Chronic Myeloid Leukemia

Sidharth TotadriPediatric Hematology-Oncology Unit, Dept. of Pediatrics, Advanced Pediatrics Center, Chandigarh, India;
,
Shankar ThipparapuPediatric Hematology-Oncology Unit, Dept. of Pediatrics, Advanced Pediatrics Center, Chandigarh, India;
,
Ritu AggarwalDept. of Immunopathology, Chandigarh, India;
,
Madhulika SharmaDept. of Immunopathology, Chandigarh, India;
,
Shano NaseemDept. of Hematology, Chandigarh, India;
,
Richa JainPediatric Hematology-Oncology Unit, Dept. of Pediatrics, Advanced Pediatrics Center, Chandigarh, India;
,
Amita TrehanPediatric Hematology-Oncology Unit, Dept. of Pediatrics, Advanced Pediatrics Center, Chandigarh, India;
,
Pankaj MalhotraClinical Hematology Unit, Dept. of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Neelam VarmaDept. of Hematology, Chandigarh, India;
&
Deepak BansalPediatric Hematology-Oncology Unit, Dept. of Pediatrics, Advanced Pediatrics Center, Chandigarh, India; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-1009-7649
ORCID Icon show all
Pages 539-544 | Received 21 Nov 2019, Accepted 19 Apr 2020, Published online: 04 May 2020

References

  • Hijiya N, Millot F, Suttorp M. Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions. Pediatr Clin North Am. 2015;62(1):107–119. doi:10.1016/j.pcl.2014.09.008.
  • de la Fuente J, Baruchel A, Biondi A, International BFM Group (iBFM) Study Group Chronic Myeloid Leukaemia Committee, et al. Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years. Br J Haematol. 2014;167(1):33–47. doi:10.1111/bjh.12977.
  • Hijiya N, Suttorp M. How I Treat Chronic Myeloid Leukemia in Children and Adolescents. Blood. 2019;133(22):2374–2384. doi:10.1182/blood.2018882233.
  • Narayanan KR, Bansal D, Walia R, et al. Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis. Pediatr Blood Cancer. 2013;60(7):1148–1153. doi:10.1002/pbc.24397.
  • Bansal D, Shava U, Varma N, Trehan A, Marwaha RK. Imatinib has adverse effect on growth in children with chronic myeloid leukemia. Pediatr Blood Cancer. 2012;59(3):481–484. doi:10.1002/pbc.23389.
  • Cervetti G, Carulli G, Galimberti S, et al. Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia. Leuk Res. 2008;32(1):191–192. doi:10.1016/j.leukres.2007.02.013.
  • de Lavallade H, Khoder A, Hart M, et al. Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling. Blood. 2013;122(2):227–238. doi:10.1182/blood-2012-11-465039.
  • Steegmann JL, Moreno G, Aláez C, et al. Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia. Haematologica. 2003;88(7):762–768.
  • Rajala HLM, Missiry ME, Ruusila A, et al. Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia. J Cancer Res Clin Oncol. 2017;143(8):1543–1554. doi:10.1007/s00432-017-2378-6.
  • Immunoglobulins IgG IgA IgM levels with electrophoresis. UK NEQAS for Immunology, Immunochemistry and Allergy, Sheffield Teaching Hospitals, NHS Foundation Trust. https://www.immqas.org.uk/pru.asp?sa=Immunoglobulins. Published January 29, 2020. Accessed April 1, 2020.
  • Grace RF, Bianchi P, van Beers EJ, et al. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study. Blood. 2018;131(20):2183–2192. doi:10.1182/blood-2017-10-810796.
  • Bansal D. Chronic Myeloid Leukemia in Children: Challenges and Opportunities: Based on 7th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 29th Sept. 2019. Indian J Pediatr. 2020; Feb 21. doi:10.1007/s12098-020-03234-x. [Epub ahead of print]
  • Walia R, Aggarwal A, Bhansali A, et al. Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia. Pediatr Hematol Oncol. 2020;37(2):99–108. doi:10.1080/08880018.2019.1689320.
  • Santachiara R, Maffei R, Martinelli S, et al. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor. Haematologica. 2008;93(8):1252–1255. doi:10.3324/haematol.12642.
  • Seiter K, Latremouille-Viau D, Guerin A, et al. Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States. Adv Ther. 2018;35(10):1671–1685. doi:10.1007/s12325-018-0772-3.
  • Reinwald M, Boch T, Hofmann WK, Buchheidt D. Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors. Biomark Insights. 2016;10(Suppl 3):55–68. doi:10.4137/BMI.S22430.
  • Inayat F, Song F, Ali NS, et al. Hepatitis B virus reactivation following imatinib therapy: A comparative review of 9 cases. J Oncol Pharm Pract. 2019;25(6):1500–1508. doi:10.1177/1078155218790337. Epub 2018 Aug 4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.